thiophenes has been researched along with Weight Gain in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (11.54) | 18.2507 |
| 2000's | 5 (19.23) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 4 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Deng, C; Han, M; Lian, J; Su, Y | 1 |
| Han, CL; Qu, CZ | 1 |
| Ikuta, T; Iwata, N; Kishi, T; Matsuda, Y; Sakuma, K | 1 |
| Deng, C; Lian, J | 1 |
| Baker, RA; Duffy, RA; Gwin, KK; McQuade, RD; Weiller, E; Weiss, C; Zhang, P | 1 |
| Eriksson, H; Newcomer, JW; Weiller, E; Weiss, C; Zhang, P | 1 |
| Dopona, EPB; Furukawa, LNS; Heimann, JC; Oliveira, IB; Rocha, VF | 1 |
| Alam, MY; Chen, Y; Jacobsen, PL; Mahableshwarkar, AR; Serenko, M | 1 |
| Carson, WH; Correll, CU; Eriksson, H; Hobart, M; McQuade, RD; Nyilas, M; Ouyang, J; Pfister, S; Sanchez, R; Skuban, A | 1 |
| Chung, MK; Hwang, KH; Jeong, EJ; Koo, SJ; Lee, J; Song, J; Yu, WJ | 1 |
| Baker, RA; Citrome, L; Nagamizu, K; Ota, A; Perry, P; Weiller, E | 1 |
| Aigbogun, MS; Duffy, R; Hartry, A; Kamat, SA; Legacy, S; Sussman, M; Yu, J | 1 |
| Gallipani, A; Markovic, M; Maroney, M; Patel, KH | 1 |
| Bencherif, M; Hauser, TA; Lippiello, PM; Lucas, R; Marrero, MB; Mazurov, A; Salet, C | 1 |
| Duenas, H; Gaynor, P; McCarberg, B; Shoemaker, S; Zheng, W | 1 |
| Chang, CP; Chao, YS; Hsiao, WC; Hsieh, WP; Hung, MS; Lin, Y; Shia, KS; Vijayakumar, RS; Yeh, YN | 1 |
| Bortolatto, CF; Chagas, PM; Nogueira, CW; Wilhelm, EA | 1 |
| Arakawa, K; Conway, B; Conway, J; Demarest, K; Du, F; Kuriyama, C; Liang, Y; Liu, Y; Martin, T; Matsushita, Y; Polidori, D; Ueta, K; Ways, K; Xu, J | 1 |
| Colman, SA; Harrison, GA; Hong, JP; Lee, MS; Lee, P; Liu, CY; Raskin, J; Ruschel, S; Shu, L; Wang, CY; Xu, X | 1 |
| Emmenegger, U; Flogerzi, B; Halter, F; Ott, K; Schuerer-Maly, CC | 1 |
| Bihun, C; Chu, I; Davis, H; Lecavalier, P; Liteplo, R; Poon, R; Yagminas, A | 1 |
| Block, N; Brock, TA; Chen, SJ; Chen, YF; Dixon, RA; Munsch, CL; Sherwood, SJ; Tilton, RG; Wu, C | 1 |
| Balansky, RM; Bennicelli, C; Dagostini, F; De Flora, S; Grubbs, CJ; Izzotti, A; Kelloff, GJ; Lubet, RA; Myers, SR | 1 |
| Camoirano, A; Cartiglia, C; De Flora, S; Izzotti, A; Tampa, E | 1 |
| de Boer, JG; Glickman, BW; Stuart, GR; Yang, H | 1 |
| Peters, G; Swiergiel, AH | 1 |
5 review(s) available for thiophenes and Weight Gain
| Article | Year |
|---|---|
Cardiovascular Risk and Safety Evaluation of a Dual Peroxisome Proliferator-Activated Receptor-Alpha/Gamma Agonist, Aleglitazar, in Patients With Type 2 Diabetes: A Meta-analysis.
Topics: Biomarkers; Blood Glucose; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Female; Glomerular Filtration Rate; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Incidence; Lipids; Male; Middle Aged; Oxazoles; PPAR alpha; PPAR gamma; Risk Assessment; Risk Factors; Thiophenes; Treatment Outcome; Weight Gain | 2020 |
Aripiprazole vs. brexpiprazole for acute schizophrenia: a systematic review and network meta-analysis.
Topics: Acute Disease; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Humans; Network Meta-Analysis; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Weight Gain | 2020 |
Changes in metabolic parameters and body weight in brexpiprazole-treated patients with acute schizophrenia: pooled analyses of phase 3 clinical studies.
Topics: Adult; Antipsychotic Agents; Clinical Trials, Phase III as Topic; Double-Blind Method; Glucose; Humans; Longitudinal Studies; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Triglycerides; Weight Gain | 2018 |
Brexpiprazole.
Topics: Antidepressive Agents; Antipsychotic Agents; Clinical Trials, Phase III as Topic; Depressive Disorder, Major; Drug Therapy, Combination; Humans; Quinolones; Receptor, Serotonin, 5-HT1A; Receptors, Dopamine D2; Schizophrenia; Thiophenes; Weight Gain | 2017 |
Weight change with long-term duloxetine use in chronic painful conditions: an analysis of 16 clinical studies.
Topics: Aged; Analgesics; Arthralgia; Chronic Disease; Controlled Clinical Trials as Topic; Diabetic Neuropathies; Duloxetine Hydrochloride; Female; Fibromyalgia; Humans; Knee Joint; Low Back Pain; Male; Middle Aged; Osteoarthritis, Knee; Pain; Thiophenes; Weight Gain; Weight Loss | 2011 |
4 trial(s) available for thiophenes and Weight Gain
| Article | Year |
|---|---|
Safety, tolerability, and efficacy of vortioxetine (Lu AA21004) in major depressive disorder: results of an open-label, flexible-dose, 52-week extension study.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Anxiety; Depression; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Humans; Male; Middle Aged; Piperazines; Psychiatric Status Rating Scales; Sexual Dysfunction, Physiological; Suicidal Ideation; Sulfides; Thiophenes; Treatment Outcome; Vortioxetine; Weight Gain; Young Adult | 2014 |
Efficacy and Safety of Brexpiprazole for the Treatment of Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Trial.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Blood Glucose; Double-Blind Method; Female; Humans; Lipids; Male; Psychiatric Status Rating Scales; Quinolones; Schizophrenia; Thiophenes; Treatment Outcome; Weight Gain | 2015 |
The effect of brexpiprazole (OPC-34712) and aripiprazole in adult patients with acute schizophrenia: results from a randomized, exploratory study.
Topics: Acute Disease; Adult; Akathisia, Drug-Induced; Antipsychotic Agents; Aripiprazole; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Quinolones; Schizophrenia; Serotonin Agents; Thiophenes; Treatment Outcome; Weight Gain | 2016 |
Once-daily duloxetine 60 mg in the treatment of major depressive disorder: multicenter, double-blind, randomized, paroxetine-controlled, non-inferiority trial in China, Korea, Taiwan and Brazil.
Topics: Activities of Daily Living; Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Blood Pressure; Brazil; China; Depressive Disorder, Major; Double-Blind Method; Duloxetine Hydrochloride; Female; Heart Rate; Humans; Korea; Male; Middle Aged; Pain; Pain Measurement; Paroxetine; Psychiatric Status Rating Scales; Taiwan; Thiophenes; Weight Gain | 2007 |
17 other study(ies) available for thiophenes and Weight Gain
| Article | Year |
|---|---|
Cevimeline co-treatment attenuates olanzapine-induced metabolic disorders via modulating hepatic M3 muscarinic receptor: AMPKα signalling pathway in female rats.
Topics: AMP-Activated Protein Kinases; Animals; Antipsychotic Agents; Female; Liver; Metabolic Diseases; Muscarinic Agonists; Olanzapine; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Signal Transduction; Thiophenes; Weight Gain | 2022 |
The dosage-dependent effects of cevimeline in preventing olanzapine-induced metabolic side-effects in female rats.
Topics: Adipose Tissue; Adiposity; Animals; Behavior, Animal; Blood Glucose; Dose-Response Relationship, Drug; Drug Interactions; Eating; Female; Locomotion; Metabolic Syndrome; Olanzapine; Open Field Test; Quinuclidines; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; Thiophenes; Treatment Outcome; Triglycerides; Weight Gain | 2020 |
The effects of brexpiprazole and aripiprazole on body weight as monotherapy in patients with schizophrenia and as adjunctive treatment in patients with major depressive disorder: an analysis of short-term and long-term studies.
Topics: Adult; Antipsychotic Agents; Aripiprazole; Depressive Disorder, Major; Female; Humans; Longitudinal Studies; Male; Meta-Analysis as Topic; Middle Aged; Quinolones; Randomized Controlled Trials as Topic; Schizophrenia; Thiophenes; Weight Gain | 2018 |
Myocardial hypertrophy induced by high salt consumption is prevented by angiotensin II AT2 receptor agonist.
Topics: Animals; Blood Pressure; Cardiomegaly; Cardiovascular Agents; Disease Models, Animal; Fibrosis; Hypertension; Male; Myocytes, Cardiac; Rats, Wistar; Receptor, Angiotensin, Type 2; Signal Transduction; Sodium Chloride, Dietary; Sulfonamides; Thiophenes; Ventricular Remodeling; Weight Gain | 2019 |
Developmental toxicity assessment of the new turf herbicide, methiozolin ([5-(2,6-difluorobenzyl)oxymethyl-5-methyl-3,3(3-methylthiophen-2-yl)-1,2-isoxazoline]), in rabbits.
Topics: Animals; Body Weight; Female; Herbicides; Isoxazoles; Male; No-Observed-Adverse-Effect Level; Pregnancy; Pregnancy Outcome; Rabbits; Thiophenes; Weight Gain | 2015 |
Cost-effectiveness of brexpiprazole adjunctive treatment for major depressive disorder.
Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antidepressive Agents; Antipsychotic Agents; Benzodiazepines; Cost-Benefit Analysis; Depressive Disorder, Major; Disorders of Excessive Somnolence; Drug Costs; Drug Therapy, Combination; Fatigue; Female; Health Care Costs; Humans; Male; Middle Aged; Models, Economic; Olanzapine; Patient Selection; Quetiapine Fumarate; Quinolones; Serotonin Agents; Thiophenes; Weight Gain; Young Adult | 2017 |
An alpha7 nicotinic acetylcholine receptor-selective agonist reduces weight gain and metabolic changes in a mouse model of diabetes.
Topics: alpha7 Nicotinic Acetylcholine Receptor; Animals; Binding, Competitive; Blood Glucose; Cell Line; Cloning, Molecular; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Electrophysiological Phenomena; Energy Metabolism; Female; Humans; Ligands; Lipid Metabolism; Mice; Mice, Inbred C57BL; Mice, Knockout; Molecular Structure; Nicotinic Agonists; Obesity; Oocytes; Patch-Clamp Techniques; Quinuclidines; Rats; Receptors, Leptin; Receptors, Nicotinic; Thiophenes; Tumor Necrosis Factor-alpha; Weight Gain; Xenopus laevis | 2010 |
Induction of fatty acid oxidation resists weight gain, ameliorates hepatic steatosis and reduces cardiometabolic risk factors.
Topics: Animals; Blood Glucose; Energy Metabolism; Fatty Acids; Fatty Liver; Hypothermia; Male; Mice; Mice, Inbred C57BL; Obesity; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Thiophenes; Weight Gain | 2012 |
High doses of 2,2'-dithienyl diselenide cause systemic toxicity in rats: an in vitro and in vivo study.
Topics: Animals; Antioxidants; Ascorbic Acid; Brain; Catalase; Chemical and Drug Induced Liver Injury; Chlorides; Drinking; Eating; Enzyme Inhibitors; Female; Glutathione; Kidney Diseases; Lipid Peroxidation; Male; Organoselenium Compounds; Oxidoreductases Acting on Sulfur Group Donors; Porphobilinogen Synthase; Rats; Rats, Wistar; Sodium-Potassium-Exchanging ATPase; Superoxide Dismutase; Thiophenes; Weight Gain; Zinc Compounds | 2013 |
Effect of canagliflozin on renal threshold for glucose, glycemia, and body weight in normal and diabetic animal models.
Topics: Animals; Blood Glucose; Body Weight; Canagliflozin; Cells, Cultured; CHO Cells; Cricetinae; Diabetes Mellitus, Experimental; Glucose Tolerance Test; Glucosides; Humans; Hyperglycemia; Kidney; Male; Mice; Mice, Inbred C57BL; Mice, Obese; Muscle, Skeletal; Rats; Rats, Zucker; Sodium-Glucose Transport Proteins; Sodium-Glucose Transporter 1; Sodium-Glucose Transporter 2; Sodium-Glucose Transporter 2 Inhibitors; Thiophenes; Weight Gain | 2012 |
Interleukin-1 and experimental gastric ulcer healing in the rat.
Topics: Animals; Female; Gastric Acid; Interleukin-1; Rats; Rats, Wistar; Stomach Ulcer; Thiophenes; Weight Gain | 1993 |
Effects of benzothiophene on male rats following short-term oral exposure.
Topics: Administration, Oral; Animal Feed; Animals; Ascorbic Acid; Dose-Response Relationship, Drug; Eating; Environmental Pollutants; Kidney; Liver; Male; Microsomes, Liver; Organ Size; Rats; Rats, Sprague-Dawley; Thiophenes; Thymus Gland; Weight Gain | 1997 |
Attenuation of pulmonary vascular hypertension and cardiac hypertrophy with sitaxsentan sodium, an orally active ET(A) receptor antagonist.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Hypertension, Pulmonary; Hypertrophy; Hypoxia; Isoxazoles; Male; Monocrotaline; Oxygen; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Thiophenes; Vasoconstriction; Weight Gain | 2000 |
Modulation of biomarkers by chemopreventive agents in smoke-exposed rats.
Topics: Acetylcysteine; Animals; Anticarcinogenic Agents; Biomarkers; DNA Adducts; DNA Damage; Eating; Hemoglobins; Inhalation Exposure; Lung; Male; Micronuclei, Chromosome-Defective; Nicotiana; Oxidation-Reduction; Plants, Toxic; Pyrazines; Rats; Rats, Sprague-Dawley; Smoke; Smoking; Thiones; Thiophenes; Tobacco Smoke Pollution; Weight Gain | 2001 |
Formation of DNA adducts in the aorta of smoke-exposed rats, and modulation by chemopreventive agents.
Topics: Acetylcysteine; Animals; Aorta, Thoracic; Arteriosclerosis; Chemoprevention; DNA Adducts; Eating; Male; Pyrazines; Rats; Rats, Sprague-Dawley; Smoking; Thiones; Thiophenes; Weight Gain | 2001 |
Modulation of 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine-induced mutation in the cecum and colon of big blue rats by conjugated linoleic acid and 1,2-dithiole-3-thione.
Topics: Animals; Animals, Genetically Modified; Anticarcinogenic Agents; Antimutagenic Agents; Bacterial Proteins; Cecum; Colon; Diet; Eating; Escherichia coli Proteins; Frameshift Mutation; Imidazoles; Lac Repressors; Linoleic Acid; Male; Mutagens; Rats; Rats, Inbred F344; Repressor Proteins; Thiones; Thiophenes; Weight Gain | 2001 |
Failure of serotonin antagonist pizotifen to stimulate feeding or weight gain in free-feeding rats.
Topics: Animals; Appetite; Diet; Drinking Behavior; Energy Metabolism; Feeding Behavior; Male; Pizotyline; Rats; Rats, Inbred Strains; Thiophenes; Weight Gain | 1990 |